Results from the Genomics Used to Improve DEpression Decisions (GUIDED) trial demonstrated that although PGx testing improved response and remission rates when compared to the usual standard of care in individuals >18 years of age with depression, it did not reach statistical significance in symptom improvement [ 100 ].
← all excerpts
A Comprehensive Analysis Examining the Role of Genetic Influences on Psychotropic Medication Response in Children.
1
—
—